Our providers can design a protocol tailored to your specific needs, drawing on the available research for each peptide in the stack
Understanding the regulatory landscape and sourcing options helps ensure access to quality products
The anti-pharma industry position is understandable, with many scandals that have plagued the industry (such as Vioxx, Oxycontin, and several others) without any accountability of the companies or their senior management
Recipients in this group can submit a claim form online to be eligible for a refund of fees
MC4R agonist FDA-approved (HSDD) as-needed 1.75 mg GPR54 agonist research-use kisspeptin-10/-54 dosing logic Neuropeptide FDA-approved (obstetric) intranasal 1040 IU Coming Soon: Queued for Coverage These compounds are indexed but not yet published
For Canadian users, domestic suppliers offer advantages including faster shipping times, reduced customs concerns, and accountability under Canadian regulations